Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Inventory: 2017-2025

Historic Inventory for ImmunityBio (IBRX) over the last 3 years, with Sep 2025 value amounting to $6.7 million.

  • ImmunityBio's Inventory rose 242.34% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 242.34%. This contributed to the annual value of $8.3 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, ImmunityBio's Inventory stood at $6.7 million, which was up 0.95% from $6.6 million recorded in Q2 2025.
  • ImmunityBio's Inventory's 5-year high stood at $8.4 million during Q1 2025, with a 5-year trough of $1.8 million in Q2 2024.
  • Over the past 2 years, ImmunityBio's median Inventory value was $6.7 million (recorded in 2025), while the average stood at $5.6 million.
  • Data for ImmunityBio's Inventory shows a peak YoY soared of 266.65% (in 2025) over the last 5 years.
  • ImmunityBio's Inventory (Quarterly) stood at $8.3 million in 2024, then spiked by 242.34% to $6.7 million in 2025.
  • Its Inventory was $6.7 million in Q3 2025, compared to $6.6 million in Q2 2025 and $8.4 million in Q1 2025.